Industry Sessions

EMUC20 features three industry sessions:

  • Friday
    Industry Presentation Telix Pharmaceuticals: “Patient’s management new perspectives in PCa & RCC” (13:45-14:00 CET)

    Industry Session Janssen: “The future is now: The role of precision medicine in advanced prostate cancer and bladder cancer” (16:30-17:15 CET)


  • Saturday

    Industry Session Bayer: “Understanding treatment options for non-metastatic castration-resistant prostate cancer (nmCRPC)” (16:15-17:00 CET)

Check out the rest of the EMUC20 Scientific and Sponsored Programme >